LOADING
Tag: Hold
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study – BioPharma Dive
February 10, 2026
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study BioPharma Dive Source link
chat_bubble0 Comment
visibility41 Views
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus – ts2.tech
December 28, 2025
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
chat_bubble0 Comment
visibility67 Views